Choosing event-driven and daily HIV pre-exposure prophylaxis - data from two European PrEP demonstration projects among men who have sex with men

被引:20
作者
Jongen, Vita W. [1 ]
Reyniers, Thijs [2 ]
Ypma, Zorah M. H. [1 ]
van der Loeff, Maarten F. Schim [1 ,3 ]
Davidovich, Udi [1 ,4 ]
Zimmermann, Hanne M. L. [1 ]
Coyer, Liza [1 ]
Elshout, Mark A. M. [1 ]
Vries, Henry J. C. [1 ,5 ]
Wouters, Kristien [2 ]
Smekens, Tom [2 ]
Vuylsteke, Bea [2 ]
Prins, Maria [1 ,3 ]
Laga, Marie [2 ]
Hoornenborg, Elske [1 ]
机构
[1] Publ Hlth Serv Amsterdam, Dept Infect Dis, Amsterdam, Netherlands
[2] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium
[3] Univ Amsterdam, Amsterdam UMC, Internal Med, Amsterdam Infect & Immun AII, Amsterdam, Netherlands
[4] Univ Amsterdam, Dept Social Psychol, Amsterdam, Netherlands
[5] Univ Amsterdam, Amsterdam UMC, Dept Dermatol, Amsterdam Infect & Immun AII,Locat Acad Med Ctr, Amsterdam, Netherlands
关键词
pre-exposure prophylaxis; sexually transmitted infections; event-driven PrEP; syphilis; men who have sex with men; HIV prevention & control; COST-EFFECTIVENESS; SAFETY; RISK;
D O I
10.1002/jia2.25768
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction Daily and event-driven PrEP are both efficacious in reducing the risk for HIV infection. However, the practice of event-driven PrEP (edPrEP) is less well studied, in particular when provided as an alternative to daily PrEP. We studied regimen preferences and switches, and sexually transmitted infection (STI) incidence. Methods We analysed pooled data from two prospective cohort studies among MSM: Be-PrEP-ared, Belgium and AMPrEP, the Netherlands. In both projects, participants could choose between daily and edPrEP at three-monthly study visits, when they were also screened for sexually transmitted infections including hepatitis C (HCV). We assessed the proportion choosing each regimen, and the determinants of choosing edPrEP at baseline. Additionally, we compared the incidence rates (IRs) of HCV, syphilis and chlamydia or gonorrhoea between regimens using Poisson regression. The study period was from 3 August 2015 until 24 September 2018. Results and discussion We included 571 MSM, of whom 148 (25.9%) chose edPrEP at baseline. 31.7% of participants switched regimen at least once. After 28 months, 23.5% used edPrEP. Older participants (adjusted odds ratio (aOR) = 1.38 per 10 years, 95% confidence interval (CI) = 1.15 to 1.64) and those unemployed (aOR = 1.68, 95% CI = 1.03 to 1.75) were more likely to initially choose edPrEP. IR of HCV and syphilis did not differ between regimens, but the IR of chlamydia/gonorrhoea was higher among daily users (adjusted incidence rate ratio = 1.61, 95% CI = 1.35 to 1.94). Conclusions A quarter of participants chose edPrEP at baseline and at 28 months this proportion was similar. Although the IR of HCV and syphilis were similar in the two regimens, the lower incidence of chlamydia and gonorrhoea among edPrEP users may suggest that less frequent STI testing of this group could be considered.
引用
收藏
页数:7
相关论文
共 31 条
  • [1] On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial
    Antoni, Guillemette
    Tremblay, Cecile
    Delaugerre, Constance
    Charreau, Isabelle
    Cua, Eric
    Castro, Daniela Rojas
    Raffi, Francois
    Chas, Julie
    Huleux, Thomas
    Spire, Bruno
    Capitant, Catherine
    Cotte, Laurent
    Meyer, Laurence
    Molina, Jean-Michel
    Meyer, L.
    Capitant, C.
    Charreau, I.
    Netzer, E.
    Leturque, N.
    Binesse, J.
    Foubert, V.
    Saouzanet, M.
    Euphrasie, F.
    Carette, D.
    Guillon, B.
    Saidi, Y.
    Aboulker, J. P.
    Spire, B.
    Suzan, M.
    Cattin, G.
    Demoulin, B.
    Sagaon-Teyssier, L.
    Lorente, N.
    Dore, V.
    Choucair, E.
    Le Mestre, S.
    Mennecier, A.
    Etien, N.
    Simon, M. C.
    Diallo, A.
    Gibowski, S.
    Delfraissy, J. F.
    Thompson, D.
    Sas, J.
    Pankovitch, J.
    Klein, M.
    Anis, A.
    Molina, J-M
    Wainberg, M. A.
    Trottier, B.
    [J]. LANCET HIV, 2020, 7 (02): : E113 - E120
  • [2] Interest in Switching to On-Demand HIV Pre-Exposure Prophylaxis (PrEP) Among Australian Users of Daily PrEP: An Online Survey
    Cornelisse, Vincent J.
    Lal, Luxi
    Price, Brian
    Ryan, Kathleen E.
    Bell, Charlotte
    Owen, Louise
    Wright, Edwina J.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (07):
  • [3] Understanding pre-exposure prophylaxis (PrEP) regimen use: Switching and discontinuing daily and event-driven PrEP among men who have sex with men
    Coyer, Liza
    van den Elshout, Mark A. M.
    Achterbergh, Roel C. A.
    Matser, Amy
    van der Loeff, Maarten F. Schim
    Davidovich, Udi
    de Vries, Henry J. C.
    Prins, Maria
    Hoornenborg, Elske
    Boyd, Anders
    [J]. ECLINICALMEDICINE, 2020, 29-30
  • [4] De Baetselier Irith, 2017, JMIR Res Protoc, V6, pe11, DOI 10.2196/resprot.6767
  • [5] Durand-Zaleski I, 2018, AIDS, V32, P95, DOI [10.1097/qad.0000000000001658, 10.1097/QAD.0000000000001658]
  • [6] A Mobile Application to Collect Daily Data on Preexposure Prophylaxis Adherence and Sexual Behavior Among Men Who Have Sex With Men: Use Over Time and Comparability With Conventional Data Collection
    Finkenflugel, Renee N. N.
    Hoornenborg, Elske
    Achterbergh, Roel C. A.
    Marra, Elske
    Davidovich, Udi
    de Vries, Henry J. C.
    Prins, Maria
    van der Loeff, Maarten E. Schim
    [J]. SEXUALLY TRANSMITTED DISEASES, 2019, 46 (06) : 400 - 406
  • [7] Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
    Fonner, Virginia A.
    Dalglish, Sarah L.
    Kennedy, Caitlin E.
    Baggaley, Rachel
    O'Reilly, Kevin R.
    Koechlin, Florence M.
    Rodolph, Michelle
    Hodges-Mameletzis, Ioannis
    Grant, Robert M.
    [J]. AIDS, 2016, 30 (12) : 1973 - 1983
  • [8] Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study
    Grant, Robert M.
    Mannheimer, Sharon
    Hughes, James P.
    Hirsch-Moverman, Yael
    Loquere, Avelino
    Chitwarakorn, Anupong
    Curlin, Marcel E.
    Li, Maoji
    Amico, K. Rivet
    Hendrix, Craig W.
    Anderson, Peter L.
    Dye, Bonnie J.
    Marzinke, Mark A.
    Piwowar-Manning, Estelle
    McKinstry, Laura A.
    Elharrar, Vanessa
    Stirratt, Michael
    Rooney, James F.
    Eshleman, Susan H.
    McNicholl, Janet M.
    van Griensven, Frits
    Holtz, Timothy H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (11) : 1712 - 1721
  • [9] Greenwald Zoe R, 2019, BMJ Open, V9, pe028768, DOI 10.1136/bmjopen-2018-028768
  • [10] Early Adopters of Event-driven Human Immunodeficiency Virus Pre-exposure Prophylaxis in a Large Healthcare System in San Francisco
    Hojilla, J. Carlo
    Marcus, Julia L.
    Silverberg, Michael J.
    Hare, C. Bradley
    Herbers, Rachel
    Hurley, Leo
    Satre, Derek D.
    Volk, Jonathan E.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (10) : 2710 - 2712